The purpose of this study is to find out whether 177Lu-DTPA-SC16.56 is a safe treatment for people with small-cell lung cancer or neuroendocrine prostate cancer

Neuroendocrine Tumor of the LungNeuroendocrine Carcinoma of LungNeuroendocrine Carcinoma+1 more

~Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT06941480

Phase 1

Biodistribution of 68Ga Pentixafor in Patients With Small Cell Lung Carcinoma (SCLC)

This is a first-in-human clinical trial evaluating the safety of an alpha-radiation treatment (Lead-212 labelled Pentixather) in patients who have been diagnos…

Carcinoid Tumor LungNeuroendocrine Tumor of the LungCarcinoma, Small-Cell Lung

~Estimated

~$10 – $7,500

Yusuf MendaNCT05557708